Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials

July 29, 2025 | News Updates
See attached press release
Read More about Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials

Centauri Therapeutics appoints Dr. Debra Barker as Chief Medical Officer

July 8, 2025 | News Updates
See attached press release
Read More about Centauri Therapeutics appoints Dr. Debra Barker as Chief Medical Officer